Showing 3 results for Rastegar
Kamand Hedayat, Saman Ahmad Nasrollahi, Hossein Rastegar, Fatemeh Zolfaghari, Alireza Firooz,
Volume 8, Issue 4 (Volume 8, Number 4 2018)
Abstract
Application of sunscreens is one of the most important ways for skin protection against sunburn, early skin aging and skin cancer.
Due to variety of sunscreen products, it is necessary to assure their protection ability against the sun’s damages. Performance assessment of sunscreens against UVB expressed by sun protection factor. Due to great cost of determination methods of this factor in foreign countries, developing a comprehensive protocol for in vivo SPF determination in Iran would have distinct benefits.
In this study four international standards have been reviewed and compared for Sun Protection Factor (SPF) determination including ISO24444, FDA2011, AS/NZS 2604:2012 and CEN 2006. The general process of in vivo SPF determination is similar in these protocols but there are some obvious differences in details that leading to advantages and disadvantages for each of them.
In this study a complete document were collected, then regarding to available facilities and with cooperation of Iran food and drug organization a comprehensive in vivo SPF determination protocol will be developed.
Kamand Hedayat, Saman Ahmad Nasrollahi, Hossein Rastegar, Fatemeh Zolfaghari, ,
Volume 9, Issue 1 (2018, Volume 9, Number 1 2018)
Abstract
Sunscreen products are among the most important ways for skin protection against sunburn, early skin aging and skin cancer. Due to existing wide variation of sunscreens, it is necessary to assure their protection ability against the sun damage. Performance assessment of sunscreen products against UVA is expressed by sun UVA protection factor (UVA-PF). Because currently these factors are determined in foreign countries at high cost, developing a comprehensive protocol for UVA-PF determination in Iran would have distinct benefits.
The two standards, CEN 2006 and FDA 2007, introduce persistent pigment darkening (PPD) method for UVA-PF in vivo determination, while following the same principles are different in details. For in vitro UVA-PF determination, 4 standards CEN 2006, FDA 2007, FDA 2011 and ISO 24443 provided protocols, which two of them (CEN 2006 and FDA 2011) proposed critical wavelength method. On the other side, FDA 2007 offered modified Diffey method. ISO 24443 approved that and considering in vitro UVA-PF determination correlated with PPD method.
In this review, complete documents were collected, and the available facilities and setups, with cooperation of Iran Center for Food and Drug Control Labs, a comprehensive UVA-PF determination protocol for Iranian sunscreen products was developed.
Hamidreza Ahmadi Ashtiani, Alireza Firooz, Hossein Rastegar, Amirhosein Askaripour,
Volume 10, Issue 4 (Volume 10, No4 2020)
Abstract
A wound is described as any laceration in normal anatomic structure and functional integrity of the skin. Chronic wounds don’t progress through the normal wound healing process in 3 months leaving open laceration of different degrees of severity. Diabetic wound healing is an insurmountable process due to the chronic nature of diabetic wounds. For these complications, this has been a challenge in the health care system. By the appearance of regenerative medicine, advisedly stem cell-based therapies and ingredients have been gained the focus of researchers and professionals as well. As there is no definite cure for diabetic wounds and forasmuch as the appearance of regenerative medicine and cell-based therapies there is a big hope to find a definite treatment for diabetic wounds. In this article novel therapies based on stem cells were observed.
